Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M93,200Revenue $M9,703Net Margin (%)32.4Altman Z-Score19.1
Enterprise Value $M91,635EPS $12.4Operating Margin %43.5Piotroski F-Score9
P/E(ttm)28.6Beneish M-Score-2.3Pre-tax Margin (%)43.3Higher ROA y-yY
Price/Book8.010-y EBITDA Growth Rate %26.5Quick Ratio2.3Cash flow > EarningsY
Price/Sales9.35-y EBITDA Growth Rate %25.5Current Ratio2.7Lower Leverage y-yY
Price/Free Cash Flow29.0y-y EBITDA Growth Rate %54.9ROA % (ttm)24.0Higher Current Ratio y-yY
Dividend Yield %--PEG1.2ROE % (ttm)31.8Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M235ROIC % (ttm)36.0Gross Margin Increase y-yY

Gurus Latest Trades with BIIB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIIBVanguard Health Care Fund 2015-03-31 Buy 0.31%$334.65 - $475.98
($394.14)
$ 396.211%New holding339,100
BIIBJoel Greenblatt 2015-03-31 Sold Out -0.014%$334.65 - $475.98
($394.14)
$ 396.211%Sold Out0
BIIBMario Gabelli 2015-03-31 Reduce$334.65 - $475.98
($394.14)
$ 396.211%Reduce 0.06%4,932
BIIBKen Fisher 2015-03-31 Add$334.65 - $475.98
($394.14)
$ 396.211%Add 2.28%81,058
BIIBKen Heebner 2014-12-31 Sold Out -0.75%$299.1 - $360.67
($323.29)
$ 396.2123%Sold Out0
BIIBVanguard Health Care Fund 2014-12-31 Sold Out -0.2%$299.1 - $360.67
($323.29)
$ 396.2123%Sold Out0
BIIBJoel Greenblatt 2014-12-31 Reduce-0.08%$299.1 - $360.67
($323.24)
$ 396.2123%Reduce 84.03%5,012
BIIBKen Heebner 2014-09-30 Buy 0.75%$299.29 - $346.3
($329.79)
$ 396.2120%New holding80,000
BIIBVanguard Health Care Fund 2014-09-30 Reduce-0.27%$299.29 - $346.3
($329.79)
$ 396.2120%Reduce 58.26%233,600
BIIBJoel Greenblatt 2014-09-30 Buy 0.1%$299.29 - $346.3
($329.79)
$ 396.2120%New holding31,391
BIIBKen Heebner 2014-06-30 Sold Out -0.95%$274 - $320.13
($300.74)
$ 396.2132%Sold Out0
BIIBKen Fisher 2014-06-30 Add0.05%$274 - $320.13
($300.74)
$ 396.2132%Add 386.61%88,885
BIIBVanguard Health Care Fund 2014-06-30 Reduce-0.03%$274 - $320.13
($301.05)
$ 396.2132%Reduce 6.62%559,700
BIIBJoel Greenblatt 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 396.2132%Sold Out0
BIIBGeorge Soros 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 396.2132%Sold Out0
BIIBRon Baron 2014-06-30 Add$274 - $320.13
($300.74)
$ 396.2132%Add 41.76%8,632
BIIBMario Gabelli 2014-06-30 Add$274 - $320.13
($301.05)
$ 396.2132%Add 16.46%4,175
BIIBKen Heebner 2014-03-31 Buy 0.95%$273.518 - $351.94
($316.4)
$ 396.2125%New holding116,000
BIIBVanguard Health Care Fund 2014-03-31 Reduce-0.24%$273.518 - $351.94
($315.54)
$ 396.2126%Reduce 32.19%599,400
BIIBGeorge Soros 2014-03-31 Buy 0.02%$273.518 - $351.94
($316.4)
$ 396.2125%New holding7,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIIB is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BIIB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Posner Brian SDirector 2015-06-22Sell470$415-1.51view
WILLIAMS DOUGLAS EEVP Research & Development 2015-06-19Sell3,841$410-0.31view
Posner Brian SDirector 2015-06-15Sell400$386.645.71view
SCANGOS GEORGE ACEO 2015-06-01Sell1,362$398.872.47view
SCANGOS GEORGE ACEO 2015-05-01Sell1,362$377.528.27view
SCANGOS GEORGE ACEO 2015-04-01Sell1,362$423.2-3.42view
Sandrock AlfredGrp SVP, Chief Medical Officer 2015-03-27Sell430$430.12-4.97view
Cox JohnEVP Pharmaceutical Oper & Tech 2015-03-25Sell12,010$449.06-8.98view
Rowinsky Eric KDirector 2015-03-20Sell11,667$475-13.95view
Rowinsky Eric KDirector 2015-03-19Sell2,333$436.14-6.28view

Quarterly/Annual Reports about BIIB:

News about BIIB:

Articles On GuruFocus.com
Investment Strategies for the Bullish Biotech Sector Jun 01 2015 
Apple, SunEdison and Biogen: Hellman, Jordan Management's Top 3 Stocks Outperform the Rise in the S& May 28 2015 
PRIMECAP Sells Portions of Its Top Two Stakes May 27 2015 
8 Top Healthcare Stocks to Watch May 13 2015 
Biogen Making A Breakthrough In Treating Alzheimer’s May 02 2015 
Vanguard Healthcare Fund Adds Four New Positions May 01 2015 
Biogen or Bluebird: Which Will Lead in SCD? Apr 30 2015 
Analysts Provide Update for Biogen, PTC Therapeutics, GW Pharma, and Isis Pharma Apr 22 2015 
Biogen And Idec To Part Ways After Inventing Alzheimer's Drug Mar 27 2015 
Biogen’s Alzheimer’s Drug Shows Promising Test Results Mar 23 2015 

More From Other Websites
1:40 am Biogen and Sobi receive Marketing Authorization Application from EMA for ALPROLIX Jun 27 2015
Biogen and Sobi announce European Medicines Agency validates Alprolix® (rFIXFc) marketing... Jun 26 2015
Biogen and Sobi Announce European Medicines Agency Validates ALPROLIX® (rFIXFc) Marketing... Jun 26 2015
Biogen and Sobi Announce European Medicines Agency Validates ALPROLIX® (rFIXFc) Marketing... Jun 26 2015
Short Sellers Get More Selective on Big Biotech Jun 25 2015
Does a Safe Biotechnology Stock Exist? Jun 24 2015
Veteran Investor Sam Isaly Picks Top Biotechs Jun 23 2015
Isis Pharmaceuticals Up on Spinal Muscular Atrophy Data - Analyst Blog Jun 23 2015
On the move: New hires and job transitions in the local life science industry Jun 23 2015
Biogen Achieves Carbon Neutrality Jun 23 2015
Perrigo Going Up With Or Without Mylan, Says BMO Jun 23 2015
These are the Fortune 500’s fastest-growing pharma companies Jun 20 2015
Biotech bargain bin Jun 19 2015
Why Biogen Is Inches Away From Changing the World Jun 19 2015
Biotech's big boost Jun 18 2015
Biogen and SELF Help Women Reimagine Daily Life with Relapsing Multiple Sclerosis (RMS) Jun 18 2015
New Biogen Hemophilia Data At ISTH Congress to Highlight Extension Study Outcomes and Pediatric Use Jun 18 2015
The Note Moving Pharma Giants Today Jun 17 2015
3 Reasons That Biogen's Shares Could Rise Jun 16 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK